Cargando…
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
Genomic studies have shown that the androgen receptor (AR) pathway plays an important role in some breast cancer subtypes. However few data are present on the concordance between AR expression in primary tumors and metastases. We investigated AR expression by using immunohistochemistry (IHC) in 164...
Autores principales: | Bronte, Giuseppe, Bravaccini, Sara, Ravaioli, Sara, Puccetti, Maurizio, Scarpi, Emanuela, Andreis, Daniele, Tumedei, Maria Maddalena, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, De Simone, Valeria, Maltoni, Roberta, Bonafè, Massimiliano, Amadori, Dino, Rocca, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036224/ https://www.ncbi.nlm.nih.gov/pubmed/29890379 http://dx.doi.org/10.1016/j.tranon.2018.05.006 |
Ejemplares similares
-
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
por: Bronte, Giuseppe, et al.
Publicado: (2018) -
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
por: Bronte, Giuseppe, et al.
Publicado: (2019) -
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
por: Bravaccini, Sara, et al.
Publicado: (2018) -
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
por: Bravaccini, Sara, et al.
Publicado: (2020) -
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer
por: Pietri, Elisabetta, et al.
Publicado: (2018)